Contrast developer Guerbet reported a drop in revenues for 2020 due to the ongoing COVID-19 pandemic.
For the full fiscal year (end-December 31), the firm posted revenue of 712.3 million euros ($862.9 million U.S.) at current exchange rates, down 12.8% compared with revenue of 816.9 million euros ($989.6 million) in 2019. However, at constant exchange rates, Guerbet's revenue was down 10% at 735.4 million euros ($890.8 million).
For diagnostic imaging in particular, revenue totaled 637.2 million euros ($771.9 million U.S.), down 11.4% at constant exchange rates, compared with 719.4 million euros ($871.5 million U.S.) in 2019.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
